Induction of apoptosis in the cervical cancer cell line HeLa by a novel metabolite extracted from the fungus Aspergillus japonicus Saito

Natural bioactive compounds have been found superior to chemical compounds for use in pharmaceutical applications. Such natural compounds include biologically active compounds present as a part of fungal metabolism that originate through different biochemical pathways and contain different structural groups like benzopyranones, phenols, toxins, and steroids. One such novel compound is a secondary metabolite extracted from the filamentous fungus Aspergillus japonicus Saito. The compound exhibited anticancer properties and was found to be harmless to normal human lymphocytes. The metabolites were separated by thin layer chromatography and screened for their cytotoxic potential through 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay in the cervical cancer cell line HeLa. Induction of apoptosis in the treated cervical cancer cell line HeLa was observed and confirmed through fluorescence microscopy, DNA fragmentation analysis, and caspase-3-enzyme activity assays. Preliminary chemical screening carried out indicated the presence of alkaloids in the bioactive fraction. The bioactive fraction was subjected to LC-MS analysis for characterization. This study indicated that the metabolite shows promise for use as an antineoplastic agent. This is the first report of an anticancer compound from A. japonicus.

Induction of apoptosis in the cervical cancer cell line HeLa by a novel metabolite extracted from the fungus Aspergillus japonicus Saito

Natural bioactive compounds have been found superior to chemical compounds for use in pharmaceutical applications. Such natural compounds include biologically active compounds present as a part of fungal metabolism that originate through different biochemical pathways and contain different structural groups like benzopyranones, phenols, toxins, and steroids. One such novel compound is a secondary metabolite extracted from the filamentous fungus Aspergillus japonicus Saito. The compound exhibited anticancer properties and was found to be harmless to normal human lymphocytes. The metabolites were separated by thin layer chromatography and screened for their cytotoxic potential through 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay in the cervical cancer cell line HeLa. Induction of apoptosis in the treated cervical cancer cell line HeLa was observed and confirmed through fluorescence microscopy, DNA fragmentation analysis, and caspase-3-enzyme activity assays. Preliminary chemical screening carried out indicated the presence of alkaloids in the bioactive fraction. The bioactive fraction was subjected to LC-MS analysis for characterization. This study indicated that the metabolite shows promise for use as an antineoplastic agent. This is the first report of an anticancer compound from A. japonicus.

___

  • Ali I, Wani WA, Saleem K (2011). Cancer scenario in India with future perspectives. Canc Ther 8: 56–70.
  • Bladt TT, Frisvad JC, Knudsen PB, Larsen TO (2013). Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi. Molecules 18: 11338–11376.
  • Bu’Lock JD (1961). Intermediary metabolism and antibiotic synthesis. Adv Appl Microbiol 3: 293–342.
  • Calton GJ, Ranieri RL, Espenshade MA (1978). Quadrone, a new antitumor substance produced by Aspergillus terreus production, isolation and properties. J Antibiot 31: 39–44.
  • Calvo MA, Wilson RA, Bok JW, Keller NP (2002). Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev 66: 447–459.
  • Cohen JJ (1993). Apoptosis. Immuno Today 14: 126–130.
  • Demain AL Fang A (2000). The natural functions of secondary metabolites. Adv Biochem Eng Biotechnol 69: 1–39.
  • Demain AL, Sanchez S (2009). Microbial drug discovery: 80 years of progress. J Antibio 62: 5–16.
  • El-Kassas HY, Khairy HM (2009). A trial for biological control of a pathogenic fungus (Fusarium solani) by some marine microorganisms. American-Eurasian J Agric Environ Sci 5: 434–440.
  • Gomez A, Gomez A (1984). Statistical Procedures for Agricultural Research. 2nd edn. New York, NY, USA: John Wiley and Sons, pp. 188–191.
  • Harborne JB (1973). Phytochemicals Methods. London, UK: Chapman and Hall Ltd., pp. 49-188.
  • Joshi VK, Attri D, Bala A, Bhushan S (2003). Microbial pigments. Ind J Biotech 2: 362–369.
  • Kinghorn AD, Chin YW, Swanson SM (2009). Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Devel 12: 189–196.
  • Lee Y, Shacter E (1999). Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 274: 19792–19798.
  • Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 16: 55–63.
  • Nielsen KF, Smedsgaard J (2003). Fungal metabolite screening: database of 474 mycotoxins and fungal metabolites for dereplication by standardised liquid chromatography–UV– mass spectrometry methodology. J Chromatogr A 1002: 111– 136.
  • Sawada K, Noda K, Nakajima H, Shimbara N, Furuichi Y, Sugimoto M (2005). Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines. Biol Pharm Bull 28: 1202–1207.
  • Selim KA, El-Beih AA, AbdEl-Rahman TM, El-Diwany AI (2012). Biology of endophytic fungi. Curr Res Environ Appl Myco 2: 31–82.
  • Sudarmono P, Utji R, Kardono LBS, Kumala S (2006). Cytotoxic assay of endophytic fungus 1.2.11 secondary metabolites from Brucea javanica (L) Merr towards cancer cell in vitro. Med J Indones 15: 137–144.
  • Teoh YP, Don MM (2013). In vitro antifungal activities and phytochemical analysis of filamentous white-rot fungi, Schizophyllum commune Sains. Malaysiana 42: 1267–1272.
  • Wainwright M (1992). An Introduction to Fungal Biotechnology. New York, NY, USA: John Wiley & Sons.
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Downregulation of c-Myc mediated ODC expression after purvalanol treatment is under control of upstream MAPK signaling axis in MCF-7 breast cancer cells

Pınar OBAKAN, Gizem ALKURT, Betsi KÖSE, Ajda ÇOKER GÜRKAN, Elif Damla ARISAN, Deniz COŞKUN, Zeynep Narçin ÜNSAL

Evaluation of MUC1, CK20, and hTERT expression in peripheral blood of gastrointestinal cancer patients in search of diagnostic criteria

Sibel KÜÇÜKYILDIRIM, Beril ERDEM, Emel SAĞLAR, Zülfikar POLAT, Hatice MERGEN

Genotoxic, cytotoxic, and apoptotic effects of crude extract of Usnea filipendula Stirt. in vitro

Serap ÇELİKLER KASIMOĞULLARI, Seyhan ORAN, Ferda ARI, Engin ULUKAYA

Current paradigms of cancer chemoprevention

Rajendra G. MEHTA

The role of ABC transporters in anticancer drug transport

Serhan KARVAR

The effect of survivin gene promoter polymorphism on breast cancer

Mehmet Deniz ALTIPARMAK, Celal İsmail BİLGİÇ, Nüzhet Cenap DENER, Esra GÜNDÜZ, Sibel YENİDÜNYA, Muradiye ACAR, Meral ŞEN, Mehmet GÜNDÜZ

Multidrug resistance in chronic myeloid leukemia

Miray ÜNLÜ, Yağmur KİRAZ, Fatma Necmiye KACI, Mehmet Ali ÖZCAN, Yusuf BARAN

Progesterone receptor modulators in breast cancer

Ronald D. WIEHLE

Identification of new genes required for the maintenance of chromosome integrity in Drosophila melanogaster

Francesca CEPRANI, Franco SPIRITO, Roberto PIERGENTILI

Induction of apoptosis in the cervical cancer cell line HeLa by a novel metabolite extracted from the fungus Aspergillus japonicus Saito

Apoorva PRABHU, Prerana VENKAT, Bharath GAJARAJ, Varalakshmi KILINGAR NADUMANE